tirzepatide pregnancy risk and Does Tirzepatide Cause Birth Defects?

Beyond the Buzz: What Are GLP-1 Medications

Tirzepatide, also known as Zepbound for weight loss, is a revolutionary FDA-approved medication that addresses obesity by acting on two key hormonal pathways

Alyssa Dominguez, an endocrinologist at the University of Southern Californias Keck School of Medicine

by the FDA The previous FDA-approved maximum dose of semaglutide for weight loss was 2.4 mg weekly by injection (Wegovy) Rushing your dose increase can backfire

Clinical efficacy: where CT-388 stands K-Dense Web curated placebo-controlled weight loss data from peer-reviewed publications (STEP 1-4, SURMOUNT-1-4, retatrutide Phase 2, CT-388 Phase 2) and applied a critical methodological filter: only Standard-design, Non-T2D trials were used for cross-drug comparisons

Both companies have introduced direct-to-consumer platforms that help reduce the barriers new patients face when trying to access these medications